Verastem, Inc.
XNAS:VSTM
10.34
$11.00 - 20.00
$7.55 - 100.00
$10.28
$10.5
$10.39
$10.64
11.25
3.46
1880155
2859815.7
65181905.56
Chart
TendieTensor AI Analysis
Company
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Fundamentals
78
-2.430000
-44.454000
-1.35
100
BBG001J2LSK5
BBG001V0G978
61.55M
66.78M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own VSTM. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.